239 related articles for article (PubMed ID: 12485413)
21. Human immunodeficiency virus type 1 tat-mediated cytotoxicity of human brain microvascular endothelial cells.
Khan NA; Di Cello F; Nath A; Kim KS
J Neurovirol; 2003 Dec; 9(6):584-93. PubMed ID: 14602571
[TBL] [Abstract][Full Text] [Related]
22. Proinflammatory synergism of ethanol and HIV-1 Tat protein in brain tissue.
Flora G; Pu H; Lee YW; Ravikumar R; Nath A; Hennig B; Toborek M
Exp Neurol; 2005 Jan; 191(1):2-12. PubMed ID: 15589507
[TBL] [Abstract][Full Text] [Related]
23. HIV-1 viral proteins gp120 and Tat induce oxidative stress in brain endothelial cells.
Price TO; Ercal N; Nakaoke R; Banks WA
Brain Res; 2005 May; 1045(1-2):57-63. PubMed ID: 15910762
[TBL] [Abstract][Full Text] [Related]
24. HIV-1 Tat-mediated effects on focal adhesion assembly and permeability in brain microvascular endothelial cells.
Avraham HK; Jiang S; Lee TH; Prakash O; Avraham S
J Immunol; 2004 Nov; 173(10):6228-33. PubMed ID: 15528360
[TBL] [Abstract][Full Text] [Related]
25. Extracellular HIV-1 Tat enhances monocyte adhesion by up-regulation of ICAM-1 and VCAM-1 gene expression via ROS-dependent NF-kappaB activation in astrocytes.
Song HY; Ryu J; Ju SM; Park LJ; Lee JA; Choi SY; Park J
Exp Mol Med; 2007 Feb; 39(1):27-37. PubMed ID: 17334226
[TBL] [Abstract][Full Text] [Related]
26. HIV-1 Tat potentiates TNF-induced NF-kappa B activation and cytotoxicity by altering the cellular redox state.
Westendorp MO; Shatrov VA; Schulze-Osthoff K; Frank R; Kraft M; Los M; Krammer PH; Dröge W; Lehmann V
EMBO J; 1995 Feb; 14(3):546-54. PubMed ID: 7859743
[TBL] [Abstract][Full Text] [Related]
27. HIV-1 Tat promotes monocyte chemoattractant protein-1 secretion followed by transmigration of monocytes.
Park IW; Wang JF; Groopman JE
Blood; 2001 Jan; 97(2):352-8. PubMed ID: 11154208
[TBL] [Abstract][Full Text] [Related]
28. Molecular programming of endothelin-1 in HIV-infected brain: role of Tat in up-regulation of ET-1 and its inhibition by statins.
Chauhan A; Hahn S; Gartner S; Pardo CA; Netesan SK; McArthur J; Nath A
FASEB J; 2007 Mar; 21(3):777-89. PubMed ID: 17197385
[TBL] [Abstract][Full Text] [Related]
29. Reactive oxygen intermediates induce monocyte chemotactic protein-1 in vascular endothelium after brief ischemia.
Lakshminarayanan V; Lewallen M; Frangogiannis NG; Evans AJ; Wedin KE; Michael LH; Entman ML
Am J Pathol; 2001 Oct; 159(4):1301-11. PubMed ID: 11583958
[TBL] [Abstract][Full Text] [Related]
30. Human immunodeficiency virus-1 Tat protein up-regulates interleukin-6 and interleukin-8 expression in human breast cancer cells.
Lee YW; Hirani AA; Kyprianou N; Toborek M
Inflamm Res; 2005 Sep; 54(9):380-9. PubMed ID: 16273337
[TBL] [Abstract][Full Text] [Related]
31. HIV-1 Tat protein-induced alterations of ZO-1 expression are mediated by redox-regulated ERK 1/2 activation.
Pu H; Tian J; Andras IE; Hayashi K; Flora G; Hennig B; Toborek M
J Cereb Blood Flow Metab; 2005 Oct; 25(10):1325-35. PubMed ID: 15829913
[TBL] [Abstract][Full Text] [Related]
32. EGCG inhibits Tat-induced LTR transactivation: role of Nrf2, AKT, AMPK signaling pathway.
Zhang HS; Wu TC; Sang WW; Ruan Z
Life Sci; 2012 May; 90(19-20):747-54. PubMed ID: 22480519
[TBL] [Abstract][Full Text] [Related]
33. Extracellular HIV type 1 Tat protein induces CD69 expression through NF-kappaB activation: possible correlation with cell surface Tat-binding proteins.
Blázquez MV; Macho A; Ortiz C; Lucena C; López-Cabrera M; Sánchez-Madrid F; Muñoz E
AIDS Res Hum Retroviruses; 1999 Sep; 15(13):1209-18. PubMed ID: 10480634
[TBL] [Abstract][Full Text] [Related]
34. HIV-TAT protein upregulates expression of multidrug resistance protein 1 in the blood-brain barrier.
Hayashi K; Pu H; Andras IE; Eum SY; Yamauchi A; Hennig B; Toborek M
J Cereb Blood Flow Metab; 2006 Aug; 26(8):1052-65. PubMed ID: 16395283
[TBL] [Abstract][Full Text] [Related]
35. Human immunodeficiency virus replication induces monocyte chemotactic protein-1 in human macrophages and U937 promonocytic cells.
Mengozzi M; De Filippi C; Transidico P; Biswas P; Cota M; Ghezzi S; Vicenzi E; Mantovani A; Sozzani S; Poli G
Blood; 1999 Mar; 93(6):1851-7. PubMed ID: 10068657
[TBL] [Abstract][Full Text] [Related]
36. Synergistic increases in intracellular Ca2+, and the release of MCP-1, RANTES, and IL-6 by astrocytes treated with opiates and HIV-1 Tat.
El-Hage N; Gurwell JA; Singh IN; Knapp PE; Nath A; Hauser KF
Glia; 2005 Apr; 50(2):91-106. PubMed ID: 15630704
[TBL] [Abstract][Full Text] [Related]
37. Differential requirement for p56lck in HIV-tat versus TNF-induced cellular responses: effects on NF-kappa B, activator protein-1, c-Jun N-terminal kinase, and apoptosis.
Manna SK; Aggarwal BB
J Immunol; 2000 May; 164(10):5156-66. PubMed ID: 10799874
[TBL] [Abstract][Full Text] [Related]
38. Effects of the Tat basic domain on human immunodeficiency virus type 1 transactivation, using chemically synthesized Tat protein and Tat peptides.
Vives E; Charneau P; van Rietschoten J; Rochat H; Bahraoui E
J Virol; 1994 May; 68(5):3343-53. PubMed ID: 8151793
[TBL] [Abstract][Full Text] [Related]
39. Lack of responsiveness of a nuclear factor-kappaB-regulated promoter to transactivation by human immunodeficiency virus 1 Tat in HeLa cells.
Kelly GD; Morris CB; Offermann MK
Virology; 1999 Oct; 263(1):128-38. PubMed ID: 10544088
[TBL] [Abstract][Full Text] [Related]
40. HIV-1 tat molecular diversity and induction of TNF-alpha: implications for HIV-induced neurological disease.
Mayne M; Bratanich AC; Chen P; Rana F; Nath A; Power C
Neuroimmunomodulation; 1998; 5(3-4):184-92. PubMed ID: 9730685
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
